AlphaFold predicted structure
CRLF1 · O75462

Mean pLDDT
80.3/ 100
Confident
422 residues
Confidence breakdown
- Very high(≥ 90)56%
- Confident(70–90)19%
- Low(50–70)8%
- Very low(< 50)18%
AlphaFold (Jumper et al., 2021) · CC BY 4.0
cytokine receptor like factor 1
Annotations refreshed 1 month ago.
Diagnostic Grade (Green)
Arthrogryposis
BIALLELIC, autosomal or pseudoautosomalFetal anomalies
BIALLELIC, autosomal or pseudoautosomalCold-induced sweating syndrome 1
cold-induced sweating syndrome
Crisponi syndrome
spinal stenosis
hereditary disease
dentures
cone-rod dystrophy 12
esophageal disorder
diaphragmatic hernia
cholelithiasis
Score is the Open Targets composite evidence score (0-1). Higher = stronger gene-disease association.
Cytokine receptor-like factor 1
Functions as secretory protein carrier chaperone that promotes cellular release (PubMed:10966616). Also functions as a cytokine subunit within the CRLF1-CLCF1 heterodimer, which engages the CNTF receptor complex (CNTFR, IL6ST/gp130, LIFR) (PubMed:10966616). As part of the CRLF-CLCF1 complex, binds to CNTFR, induces dimerization of the IL6ST/gp130 and LIFR, which activates JAK tyrosine kinases (JAK1 or JAK2 and to lesser extent TYK2) bound to their intracellular domains (PubMed:11294841). These kinases subsequently phosphorylate IL6ST/gp130 and LIFR (PubMed:11294841). The tyrosine phosphorylated signaling receptors serve in turn as docking sites for recruitment and activation of signal transducer and activators of transcription (STAT3 and to lesser extent STAT1) (PubMed:10966616, PubMed:11294841). Moreover, CLCF1/CLF heterodimer induces tyrosine phosphorylation of PTPN11, that associates with IL6ST/gp130-LIFR, which in turn recruits PIK3 protein kinase followed by AKT protein phosphorylation (PubMed:11294841). Participates in the survival of embryonic motor neurons (PubMed:10966616). May also play a regulatory role in the immune system (PubMed:9686600)
CRLF1 · O75462

Mean pLDDT
80.3/ 100
Confident
422 residues
Confidence breakdown
AlphaFold (Jumper et al., 2021) · CC BY 4.0